comparemela.com

Latest Breaking News On - Cellular molecular biology - Page 1 : comparemela.com

Covid-19 antidote VINCOV-19 ready for Phase-3 trials, market authorisation

The University of Hyderabad (UoH) and the Centre for Cellular Molecular Biology (CCMB) in collaboration with VINS Bioproducts Limited, a leading immunological company based in Hyderabad, announced the successful completion of the Phase-two clinical trials of VINCOV-19, India s first antidote and a cure against SARS-CoV-2 virus.

Welcome To IANS Live - LatestNews - Covid-19 antidote VINCOV-19 ready for Phase-3 trials, market authorisation

Covid-19 antidote VINCOV-19 ready for Phase-3 trials, market authorisation

The University of Hyderabad (UoH) and the Centre for Cellular Molecular Biology (CCMB) in collaboration with VINS Bioproducts Limited, a leading immunological company based in Hyderabad, announced the successful completion of the Phase-two .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.